Caption Management, LLC Pds Biotechnology Corp Transaction History
Caption Management, LLC
- $5.74 Billion
- Q3 2024
A detailed history of Caption Management, LLC transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Caption Management, LLC holds 100,000 shares of PDSB stock, worth $167,000. This represents 0.01% of its overall portfolio holdings.
Number of Shares
100,000
Previous 119,000
15.97%
Holding current value
$167,000
Previous $348,000
9.77%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding PDSB
# of Institutions
64Shares Held
4.32MCall Options Held
253KPut Options Held
70.4K-
Vanguard Group Inc Valley Forge, PA1.52MShares$2.54 Million0.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$813,2340.0% of portfolio
-
Geode Capital Management, LLC Boston, MA415KShares$693,2380.0% of portfolio
-
Inspirion Wealth Advisors, LLC344KShares$575,1370.18% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny234KShares$391,1290.0% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $47.5M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...